International Journal of Molecular Sciences | |
Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model | |
Ewa Maj3  Beata Filip-Psurska3  Marta Świtalska3  Andrzej Kutner1  Joanna Wietrzyk3  Roman Perez-Fernandez2  | |
[1]Pharmaceutical Research Institute, Rydygiera 8, 01-793 Warsaw, Poland | |
[2] | |
[3]Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, PolandLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wroclaw, Poland | |
关键词: NSCLC; imatinib; vitamin D analogs; | |
DOI : 10.3390/ijms161126016 | |
来源: mdpi | |
【 摘 要 】
In previous papers, we presented data on studies on the anticancer activity of the vitamin D3 analogs, named PRI-2191 and PRI-2205, in different cancer models. In this study, we showed the improved antiproliferative activity of a combination of imatinib mesylate (Gleevec, GV) and cytostatic agents in
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190003403ZK.pdf | 2483KB | download |